358 related articles for article (PubMed ID: 19578761)
1. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
Kobayashi H; Kajiwara H; Kanayama S; Yamada Y; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
Oncol Rep; 2009 Aug; 22(2):233-40. PubMed ID: 19578761
[TBL] [Abstract][Full Text] [Related]
2. Theoretical model of treatment strategies for clear cell carcinoma of the ovary: focus on perspectives.
Yoshida S; Furukawa N; Haruta S; Tanase Y; Kanayama S; Noguchi T; Sakata M; Yamada Y; Oi H; Kobayashi H
Cancer Treat Rev; 2009 Nov; 35(7):608-15. PubMed ID: 19665848
[TBL] [Abstract][Full Text] [Related]
3. Risk of carcinoma in women with ovarian endometrioma.
Kobayashi H; Kajihara H; Yamada Y; Tanase Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Naruse K; Sado T; Oi H
Front Biosci (Elite Ed); 2011 Jan; 3(2):529-39. PubMed ID: 21196332
[TBL] [Abstract][Full Text] [Related]
4. Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary.
Yamada Y; Shigetomi H; Onogi A; Haruta S; Kawaguchi R; Yoshida S; Furukawa N; Nagai A; Tanase Y; Tsunemi T; Oi H; Kobayashi H
Int J Gynecol Cancer; 2011 Oct; 21(7):1200-7. PubMed ID: 21885986
[TBL] [Abstract][Full Text] [Related]
5. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
[TBL] [Abstract][Full Text] [Related]
6. New insights into pattern recognition receptors and their ligands in gynecologic pathologies.
Yamada Y; Shigetomi H; Onogi A; Haruta S; Kawaguchi R; Yoshida S; Furukawa N; Nagai A; Tanase Y; Tsunemi T; Oi H; Kobayashi H
Hum Immunol; 2011 Mar; 72(3):213-8. PubMed ID: 21167248
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
[TBL] [Abstract][Full Text] [Related]
8. An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway.
Yamamoto S; Tsuda H; Suzuki K; Takano M; Tamai S; Matsubara O
Virchows Arch; 2009 Sep; 455(3):261-70. PubMed ID: 19655165
[TBL] [Abstract][Full Text] [Related]
9. Endometriosis and the development of malignant tumours of the pelvis. A review of literature.
Van Gorp T; Amant F; Neven P; Vergote I; Moerman P
Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):349-71. PubMed ID: 15157647
[TBL] [Abstract][Full Text] [Related]
10. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O
J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856
[TBL] [Abstract][Full Text] [Related]
11. The role of iron in the pathogenesis of endometriosis.
Kobayashi H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
Gynecol Endocrinol; 2009 Jan; 25(1):39-52. PubMed ID: 19165662
[TBL] [Abstract][Full Text] [Related]
12. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I
Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075
[TBL] [Abstract][Full Text] [Related]
13. A potential link of oxidative stress and cell cycle regulation for development of endometriosis.
Shigetomi H; Higashiura Y; Kajihara H; Kobayashi H
Gynecol Endocrinol; 2012 Nov; 28(11):897-902. PubMed ID: 22591187
[TBL] [Abstract][Full Text] [Related]
14. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
Chew S; Tham KF; Ratnam SS
Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
[TBL] [Abstract][Full Text] [Related]
15. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
Munksgaard PS; Blaakaer J
Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
[TBL] [Abstract][Full Text] [Related]
16. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Konishi I
Cancer Lett; 2011 Nov; 310(2):129-33. PubMed ID: 21802200
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities.
Shigetomi H; Tsunemi T; Haruta S; Kajihara H; Yoshizawa Y; Tanase Y; Furukawa N; Yoshida S; Sado T; Kobayashi H
Cancer Invest; 2012 Jul; 30(6):473-80. PubMed ID: 22530740
[TBL] [Abstract][Full Text] [Related]
18. Endometriosis and the neoplastic process.
Varma R; Rollason T; Gupta JK; Maher ER
Reproduction; 2004 Mar; 127(3):293-304. PubMed ID: 15016949
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics of ovarian carcinomas associated with endometriosis.
Kondi-Pafiti A; Papakonstantinou E; Iavazzo C; Grigoriadis C; Salakos N; Gregoriou O
Arch Gynecol Obstet; 2012 Feb; 285(2):479-83. PubMed ID: 21717140
[TBL] [Abstract][Full Text] [Related]
20. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
